- Home
- » Tags
- » Janus kinase
Top View
- Dual Inhibition of Jak2 and STAT5 Enhances Killing of Myeloproliferative Neoplasia Cells
- Janus Kinase 1 Is Required for Transcriptional Reprograming of Murine Astrocytes in Response to Endoplasmic Reticulum Stress
- DARPP-32 Promotes ERBB3-Mediated Resistance to Molecular Targeted Therapy in EGFR-Mutated Lung Adenocarcinoma
- MET-Oncogenic and JAK2-Inactivating Alterations Are Independent Factors That Affect Regulation of PD-L1 Expression in Lung Cancer
- Erbb3 Drives Mammary Epithelial Survival and Differentiation During Pregnancy and Lactation Michelle M
- Interleukin-12 Bypasses Common Gamma-Chain Signalling in Emergency Natural Killer Cell Lymphopoiesis
- PRODUCT INFORMATION TG101209 Item No
- JAK: No Longer ‘Just Another Kinase’
- PDGF Stimulates Tyrosine Phosphorylation of JAK 1 Protein Tyrosine Similar to Other Receptor Tyrosine Kinases Stimulates Its Intrinsic Kinase in Human Mesangial Cells
- Molecular Mechanisms of Cardiotoxicity Induced by Erbb Receptor Inhibitor Cancer Therapeutics
- Factor-Induced Receptor Ubiquitination and Mediates
- Structure of the Pseudokinase–Kinase Domains from Protein Kinase TYK2 Reveals a Mechanism for Janus Kinase (JAK) Autoinhibition
- JAK Kinases in Health and Disease: an Update Arian Laurence1, Marko Pesu2,3, Olli Silvennoinen2,3 and John O’Shea*,1
- Enzymatic Characterization of Wild-Type and Mutant Janus Kinase 1
- HER2, HER3, and TROP2 As Therapeutic Targets in Different Cancers
- A Role for Janus Kinases in Crosstalk Between Erbb3 and the Interferon-Alpha Signaling Complex in Myeloma Cells
- Targeting the Jak/STAT Pathway for Immunosuppression J J O’Shea
- Pharmacological Research Role of RET Protein-Tyrosine Kinase
- UC San Diego UC San Diego Previously Published Works
- A New Look at Platelet-Derived Growth Factor in Renal Disease
- Prospect for Anti-HER2 Receptor Therapy in Breast Cancer
- Kinase Inhibitors in the Treatment of Immune-Mediated Disease Apostolos Kontzias1, Arian Laurence1, Massimo Gadina2 and John J
- Cytokine Receptors Region of Janus Kinase 1 Interact with Two Distinct
- HER Kinase Inhibitor Neratinib Compared with Lapatinib: Implications for the Treatment of HER2- Positive and HER2-Mutated Breast Cancer
- Role of JAK/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial–Mesenchymal Transition
- JAK2, STAT3 and SOCS3 Gene Expression in Women with and Without Breast Cancer
- Janus Kinase 2 Is Required for the Initiation but Not Maintenance of Prolactin-Induced Mammary Cancer
- Structure-Based Design of Specific Inhibitors of Janus Kinase 3 As Apoptosis-Inducing Antileukemic Agents1
- Identifying the Role of Janus Kinase 1 in Mammary Gland Development and Breast Cancer
- FLT3) Is Overexpressed in a Subgroup of Multiple Myeloma Patients with Inferior Prognosis
- Variable IPSS DIPSS DIPSS-Plus
- (JAK) Inhibitors in the Cardiovascular System in Patients with Rheumatoid Arthritis
- Tyrosine Kinase Receptor-Activated Signal Transduction Pathways Which Lead to Oncogenesis
- Activating FLT3 Mutations Are Detectable in Chronic and Blast Phases of Chronic Myeloproliferative Disorders Other Than Chronic Myeloid Leukemia
- Association and Direct Activation of Signal Transducer and Activator of Transcription1alpha by Platelet-Derived Growth Factor Receptor
- Janus Kinase Inhibitors Mechanisms of Action